Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate for noisy respiratory secretions at the end of life
ACTRN12611000484943Phase 2Not yet recruiting
- Sponsor
- Dr Caitlin Sheehan
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing Glycopyrrolate with Placebo (2 arms). Primary endpoint: Feasibility by accrual of 24 patients in 12 months. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
glycopyrronium
Beyond the preview
Go deeper on ACTRN12611000484943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000484943.